These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9122451)

  • 1. Quality assurance in radiotherapy of prostatic cancer.
    Cellini N; Morganti AG; Luzi S; Balducci M; Salvi G
    Rays; 1996; 21(4):663-71. PubMed ID: 9122451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance in radiotherapy of head and neck tumors.
    Ausili-Cefaro G; Morganti AG; Palazzoni G; Marmiroli L
    Rays; 1996; 21(4):600-11. PubMed ID: 9122445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I; Pintilie M; Potvin M; McGowan T
    Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technological advances in radiotherapy for the treatment of localised prostate cancer.
    Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
    Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer.
    Boehmer D; Bohsung J; Eichwurzel I; Moys A; Budach V
    Radiother Oncol; 2004 Jun; 71(3):319-25. PubMed ID: 15172148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical aspects of inverse-planned intensity-modulated radiation therapy for prostate cancer: a radiation treatment planner's perspective.
    Parker W; Patrocinio H
    Can J Urol; 2005 Jun; 12 Suppl 2():48-52. PubMed ID: 16018834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research trends in the treatment of prostatic neoplasms.
    Cellini N; Luzi S; Morganti AG; Leone M; Mattiucci GC; Smaniotto D
    Rays; 2000; 25(3):371-3. PubMed ID: 11367904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance for 3D conformal radiation therapy.
    Purdy JA; Harms WB
    Strahlenther Onkol; 1998 Oct; 174 Suppl 2():2-7. PubMed ID: 9810330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
    Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
    Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
    Bayley AJ; Catton CN; Haycocks T; Kelly V; Alasti H; Bristow R; Catton P; Crook J; Gospodarowicz MK; McLean M; Milosevic M; Warde P
    Radiother Oncol; 2004 Jan; 70(1):37-44. PubMed ID: 15036850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects.
    Polgár C; Fodor J; Major T; Takácsi-Nagy Z; Kásler M; Hammer J; Van Limbergen E; Németh G
    Strahlenther Onkol; 2002 Nov; 178(11):597-606. PubMed ID: 12426670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epinal radiotherapy accident: passed, present, future].
    Peiffert D; Simon JM; Eschwege F
    Cancer Radiother; 2007 Nov; 11(6-7):309-12. PubMed ID: 17962063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
    Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
    Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance program in radiotherapy for carcinoma of the uterine cervix.
    Smaniotto D; Mantello G; Valentini V
    Rays; 1996; 21(4):641-8. PubMed ID: 9122449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physical brachytherapy planning].
    Muskalla K
    Praxis (Bern 1994); 2001 Sep; 90(36):1532-43. PubMed ID: 11593909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer.
    Hoogeman MS; van Herk M; de Bois J; Lebesque JV
    Radiother Oncol; 2005 Feb; 74(2):177-85. PubMed ID: 15734206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New trends in prostatic cancer research. Three-dimensional conformal radiation therapy (3-D CRT), brachytherapy, and new therapeutic modalities.
    Perez CA; Michalski JM; Purdy JA; Lockett MA
    Rays; 2000; 25(3):331-43. PubMed ID: 11367899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.